Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada
- PMID: 10497371
- DOI: 10.1002/(sici)1099-0496(199910)28:4<231::aid-ppul1>3.0.co;2-2
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada
Abstract
Cystic fibrosis (CF) is a complex illness characterized by chronic lung infection leading to deterioration in function and respiratory failure in over 85% of patients. An understanding of the risk factors for that progression and the interaction of these factors with current therapeutic strategies should materially improve the prevention of this progressive lung disease. The Epidemiologic Study of Cystic Fibrosis (ESCF) was therefore designed as a multicenter, longitudinal, observational study to prospectively collect detailed clinical, therapeutic, microbiologic, and lung function data from a large number of CF treatment sites in the U.S. and Canada. The ESCF also serves an important role as a phase-IV study of dornase alfa. To be eligible for enrollment, subjects must have the diagnosis of CF and receive the majority of their care at an ESCF site. In this paper, the authors present the ESCF study design in detail. Further, enrollment data collected at 194 study sites in 18,411 subjects enrolled from December 1, 1993 to December 31, 1995 are presented in summary form. This comprehensive study is unique in the detail of clinical data collected regarding patient monitoring and therapeutic practices in CF care. Two companion articles present data regarding practice patterns in cystic fibrosis care, including data on resource utilization and prescribing practices.
Copyright 1999 Wiley-Liss, Inc.
Similar articles
-
Epidemiologic Study of Cystic Fibrosis: 25 years of observational research.Pediatr Pulmonol. 2021 May;56(5):823-836. doi: 10.1002/ppul.25248. Epub 2021 Jan 12. Pediatr Pulmonol. 2021. PMID: 33434406 Free PMC article. Review.
-
Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis.Chest. 1999 Sep;116(3):639-46. doi: 10.1378/chest.116.3.639. Chest. 1999. PMID: 10492265
-
Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.Pediatr Pulmonol. 1999 Oct;28(4):242-7. doi: 10.1002/(sici)1099-0496(199910)28:4<242::aid-ppul2>3.0.co;2-w. Pediatr Pulmonol. 1999. PMID: 10497372
-
Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States.Am J Respir Crit Care Med. 2018 Mar 15;197(6):768-775. doi: 10.1164/rccm.201707-1541OC. Am J Respir Crit Care Med. 2018. PMID: 29099606 Free PMC article.
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2015 Oct 9;(10):CD008649. doi: 10.1002/14651858.CD008649.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2018 Feb 09;2:CD008649. doi: 10.1002/14651858.CD008649.pub3. PMID: 26451533 Updated. Review.
Cited by
-
Semiparametric Regression Estimation for Recurrent Event Data with Errors in Covariates under Informative Censoring.Int J Biostat. 2016 Nov 1;12(2):/j/ijb.2016.12.issue-2/ijb-2016-0001/ijb-2016-0001.xml. doi: 10.1515/ijb-2016-0001. Int J Biostat. 2016. PMID: 27497870 Free PMC article.
-
Tolerance of 7% Hypertonic Saline in Pediatric Cystic Fibrosis Patients.Pediatr Allergy Immunol Pulmonol. 2020 Jun;33(2):63-68. doi: 10.1089/ped.2019.1127. Pediatr Allergy Immunol Pulmonol. 2020. PMID: 35921579 Free PMC article.
-
IL1B polymorphisms modulate cystic fibrosis lung disease.Pediatr Pulmonol. 2009 Jun;44(6):580-93. doi: 10.1002/ppul.21026. Pediatr Pulmonol. 2009. PMID: 19431193 Free PMC article.
-
Vitamin K supplementation for cystic fibrosis.Cochrane Database Syst Rev. 2020 Jun 4;6(6):CD008482. doi: 10.1002/14651858.CD008482.pub6. Cochrane Database Syst Rev. 2020. PMID: 32497260 Free PMC article.
-
Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis.J Pediatr. 2009 Nov;155(5):634-9.e1-4. doi: 10.1016/j.jpeds.2009.04.059. Epub 2009 Jul 16. J Pediatr. 2009. PMID: 19608199 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical